AI Verdict
ILST has stronger fundamentals based on our AI analysis.
IMDX vs ILST Fundamental Comparison
| Metric | IMDX | ILST |
|---|---|---|
| Revenue | $4.1M | $0.0 |
| Net Income | $-50.2M | $-4.6M |
| Net Margin | -1,238.5% | N/A |
| ROE | N/A | N/A |
| ROA | -195.0% | -10,786.8% |
| Current Ratio | 1.27x | 0.03x |
| Debt/Equity | N/A | N/A |
| EPS | $-1.65 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMDX vs ILST: Frequently Asked Questions
Is IMDX or ILST a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ILST has stronger fundamentals. IMDX is rated STRONG SELL (88% confidence) while ILST is rated STRONG SELL (98% confidence). This is not investment advice.
How does IMDX compare to ILST fundamentally?
Insight Molecular Diagnostics Inc. has ROE of N/A vs INTERNATIONAL STAR INC's N/A. Net margins are -1,238.5% vs N/A respectively.
Which stock pays higher dividends, IMDX or ILST?
IMDX has a dividend yield of N/A or no dividend while ILST has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMDX or ILST for long term?
For long-term investing, consider that IMDX has STRONG SELL rating with 88% confidence, while ILST has STRONG SELL rating with 98% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMDX vs ILST?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMDX vs ILST, the AI consensus favors ILST based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.